Detalhe da pesquisa
1.
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
N Engl J Med;
390(5): 397-408, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38294972
2.
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).
Clin Infect Dis;
77(8): 1102-1110, 2023 10 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37338158
3.
Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate.
J Allergy Clin Immunol;
143(4): 1395-1402, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30537475
4.
Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life.
Allergy Asthma Proc;
34(3): 274-82, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23676577
5.
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Hum Vaccin Immunother;
19(2): 2235238, 2023 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37529944
6.
Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies.
Pediatr Infect Dis J;
42(11): 1021-1028, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37566897
7.
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors.
Hum Vaccin Immunother;
19(1): 2177066, 2023 12 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36864601
8.
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE).
Vaccine;
40(9): 1342-1351, 2022 02 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35039194
9.
Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis.
Allergy Asthma Proc;
32(2): 159-67, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21439168
10.
Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis.
J Allergy Clin Immunol;
125(6): 1247-1253.e5, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20434199
11.
Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.
J Allergy Clin Immunol Pract;
8(5): 1634-1644.e1, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31981733
12.
A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J;
39(8): 763-770, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32639460
13.
Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler.
Pediatr Pulmonol;
52(3): 310-318, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27740721
14.
Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects.
Hum Vaccin Immunother;
12(8): 2142-2147, 2016 08 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27149114
15.
Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
Pediatr Pulmonol;
49(5): 441-50, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24019197
16.
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
Respir Med;
107(5): 656-64, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23490226
17.
Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
Am J Rhinol Allergy;
27(2): 102-8, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23562197
18.
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial.
Int J Chron Obstruct Pulmon Dis;
7: 43-55, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22334768
19.
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD.
Int J Chron Obstruct Pulmon Dis;
7: 57-71, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22334769
20.
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.
Int J Chron Obstruct Pulmon Dis;
7: 73-86, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22334770